Journal of Fertility Biomarkers

Journal of Fertility Biomarkers

Journal of Fertility Biomarkers – Editors Guidelines

Open Access & Peer-Reviewed

Submit Manuscript

Editors Guidelines

Guidance for editors overseeing fertility biomarker submissions.

Quality ReviewMaintain rigorous evaluation standards.
Timely DecisionsKeep review cycles efficient.
Ethical OversightProtect patient privacy.
Clinical ImpactSupport evidence based care.

Journal at a Glance

ISSN: 2576-2818
DOI Prefix: 10.14302/issn.2576-2818
License: CC BY 4.0
Peer reviewed open access journal

Scope Alignment

Fertility biomarkers, reproductive endocrinology, ovarian reserve assessment, male factor diagnostics, embryo and endometrial evaluation, and translational biomarker validation. We prioritize evidence that improves reproductive outcomes and clinical decision making.

Publishing Model

Open access, single blind peer review, and rapid publication after acceptance and production checks. Metadata validation and DOI registration are included.

Review Time09 daysFrom submission
Acceptance Rate52%Current average
Decision Time12 daysSubmission to decision
Publication3 daysAfter acceptance
Editor Responsibilities

Editors guide the peer review process and ensure that published research meets JFB standards for methodological rigor and fertility biomarker relevance.

Editors are expected to provide timely decisions, manage reviewer selection, and uphold ethical standards.

Key Duties
  • Conduct initial scope and ethics screening
  • Select reviewers with fertility biomarker expertise
  • Evaluate reviewer comments and decision recommendations
  • Ensure reporting standards and data transparency compliance
  • Communicate clear revision guidance to authors
Decision Framework

Scope Fit

Alignment with fertility biomarker research and care.

Methodology

Robust assay and outcomes reporting.

Impact

Relevance to clinical practice or policy.

Integrity

Ethical compliance and transparency.

Best Practices
  • Use standardized decision letters
  • Encourage adherence to CONSORT, STROBE, or PRISMA
  • Flag potential conflicts of interest
  • Escalate integrity concerns promptly
  • Promote data availability and reproducibility
  • Encourage consistent decision letters and clear revision guidance.
  • Ensure reviewer expertise matches fertility biomarker subtopics.
  • Confirm ethics approvals and patient consent documentation.
  • Monitor turnaround times and communicate delays promptly.
  • Promote data transparency and reproducibility statements.
  • Document conflicts of interest and recuse when needed.
  • Coordinate with guest editors to align on scope fit.
  • Verify clinical trial registration and reporting quality.
  • Ensure statistical review for complex biomarker studies.
  • Request data access statements for sensitive clinical datasets.
  • Encourage adherence to CONSORT, STROBE, PRISMA, or CARE.
  • Check that imaging and laboratory reporting are adequate.
Editor FAQ

How many manuscripts should I handle?

Assignment volume depends on expertise and availability.

What if reviews conflict?

Provide balanced guidance and request an additional review if needed.

How do I handle ethical concerns?

Notify the editorial office at [email protected].

JFB Commitment

JFB is committed to rigorous, transparent publishing in fertility biomarker research and reproductive medicine. We emphasize reproducible laboratory methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in biomarker validation, reproductive outcomes, and translational fertility science.

Interested in Serving as an Editor?

Join the editorial team to guide fertility biomarker research.